Looks like Christine Brown has been accepted as a keynote speaker i.e. will run a 30 minute session live on stage ... prime-time slot.
So not only will we get two sessions talking about our trial specifically, Christine Brown will get a 'prime-time' 30 minute slot to talk about CAR T vs GBM more broadly (may give mention to our CLTX trial, along with Mustang Bio's IL13Rα2 targeting CAR-T). Either way, it's great exposure, and I'm seriously impressed by how much publicity our trial is getting for a first cohort phase 1 trial read out.. in a forum where it really matters i.e. the SNO, not so much on the ASX, where hardly anyone has heard of CHM yet... I have a feeling that is going to change in the not too distant future.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)